New research featured in Nature Biotechnology studies the impact of the funding by the National Institutes of Health in the field of cancer research. Using patents as proxies, it finds evidence for a productivity slowdown around 1995. The study suggests that the results are in line with an incremental, rather than a high-risk high-rewards funding strategy by the federal agencies.
Results of a two-year update of the world's first comparative trial of mass drug administration against scabies, show that the infection rate is still significantly down. The latest findings are published today in the New England Journal of Medicine. In 2012, the Murdoch Children's Research Institute, the Kirby Institute and the Fiji Ministry for Health, treated almost everyone on a remote Fijian island (716 people) with the oral anti-parasitic drug ivermectin.
A quantitative analysis going back over a period of more than 90 years shows that almost a third of patents in the US rely on federal research funding.
A New Jersey team of researchers has reported the first case of successful, long-term relief of chronic refractory shoulder pain in a wheelchair user with spinal cord injury following a single injection of autologous, micro-fragmented adipose tissue. The article (doi: 10.1038/s41394-019-0186-8) was epublished ahead of print on May 13, 2019 by Spinal Cord Series and Cases. This Editors' Choice article is Open Access through June 30: https://www.nature.com/articles/s41394-019-0186-8
Participants in research are motivated by learning, teaching opportunities.
Institutions, science funders, data repositories, publishers, researchers and scientific societies from all scientific disciplines must work together to ensure all scientific data are easy to find, access and use, according to a new commentary in Nature by members of the Enabling FAIR Data Steering Committee.
Scientific research usually takes months to be published by academic journals, and once it is, many of the papers can only be read by scientists from wealthy institutes that subscribe to the journals. Over the years, there have been various attempts to make research more widely available, but most papers remain behind paywalls and scientists complain that the peer review process at journals now takes longer than ever.
A new study by SMU Associate Professor Reddi Kotha reveals that language choices alone can influence whether inventors receive financial backing from their organizations.
Over one-third of all FDA-approved drugs act on a specific family of proteins: G-protein coupled receptors (GPCRs). Drugs to treat high blood pressure, asthma, cancer, diabetes and myriad other conditions target GPCRs throughout the body--but a recent study shows what happens next. In results published in Cell, researchers outline the timeline of events, including precisely when and how different parts of a GPCR interacts with its G protein signaling partners.
Georgia Institute of Technology researchers found how long an entrepreneur displays the highest level of excitement during a pitch also plays a major role in predicting success in receiving funding.